45.80
0.00
(0.00%)
As of April 15 at 8:05:42 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 19.33M | 19.81M | 79.41M | 93.49M |
| Low Estimate | 19.2M | 19.3M | 78M | 88M |
| High Estimate | 19.46M | 20.31M | 80.81M | 98.98M |
| Year Ago Sales | 17.6M | 17.93M | 73.24M | 79.41M |
| Sales Growth (year/est) | 9.85% | 10.47% | 8.41% | 17.74% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 46K.F | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Reiterates | Roth MKM: Buy to Buy | 2/14/2025 |
| Maintains | Roth MKM: Buy to Buy | 8/2/2024 |
| Maintains | Roth Capital: Buy | 8/2/2021 |
| Upgrade | Roth Capital: Neutral to Buy | 7/31/2017 |
| Downgrade | Roth Capital: Buy to Neutral | 10/5/2016 |
| Maintains | Roth Capital: Buy | 4/4/2016 |